Trice Medical has secured CE mark and Health Canada approval for the mi-eye 2 handheld, single-use and disposable direct visualization tool.

The company announced the completion of its first successful case performed with mi-eye 2 devices in the United Kingdom.

Today's case was performed by Mr. Tony Andrade, a Consultant Orthopaedic Surgeon at Circle Reading Hospital.

 "This is a fantastic opportunity to be able to show patients what's going on inside their joints and talk them through it live as you see the pathology. This is something that's been needed for a long time to aid patient's understanding of their condition. It's useful not just for diagnostic purposes, but it allows for the delivery of injections into the appropriate targeted area," said Mr. Andrade.

The early success of Trice Medical's mi-eye 2, which was launched in the U.S. in 2017, has captured the attention of medical professionals who are embracing the technology as a new diagnostic modality. After the first year of commercial launch, the mi-eye is currently being used by over 200 institutions across the states.

The disposable needle embedded with a wide-angle camera lens enables physicians to diagnose joint injuries right in their clinic, and provide their patients with immediate answers to the cause of their pain.

Trice Medical chief commercialization officer and worldwide sales vice president Mark Foster said: Trice is proud and excited to be commercializing the mi-eye 2 into Europe and Canada. MRI and Ultrasound will always be good options for patients with sports injuries.

“We are thrilled to add disposable in-clinic arthroscopy to the list of available tools physicians have to be able to assess joint injuries. In many countries, the mi-eye 2 has a chance to save weeks to months of the treatment pathway to surgery AND provide a dynamic image of the joint. The is truly an example of innovation in the new world of value-based medicine.”

Trice Medical's mi-eye 2, is a handheld, single-use, and disposable direct visualization tool. The mi-eye 2 was specifically designed for use in the clinic setting, consisting of a single stick percutaneous, and self-blunting design which deploys an integrated camera and a light source.

The procedure is performed with local anesthetic and provides patients with an alternative to traditional diagnostic modalities, such as time-consuming and often inaccurate MRIs.

 The mi-eye is indicated for use in diagnostic and operative arthroscopic and endoscopic procedures to provide illumination and visualization of an interior cavity of the body through either a natural or surgical opening. mi-eye 2 is available for prescription use only.